<DOC>
	<DOCNO>NCT00646841</DOCNO>
	<brief_summary>The primary objective determine effect Gastrointestinal Therapeutic System ( GITS ) formulation Doxazosin use combination therapy 5 major class antihypertensive agent measure 24-hour diastolic blood pressure .</brief_summary>
	<brief_title>Effects Doxazosin Gastrointestinal Therapeutic System Ambulatory Blood Pressure Cardiovascular Risk Factors Uncontrolled Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<criteria>Eligible subject male female ≥18 year age diagnosis primary essential hypertension currently take 1 2 individual antihypertensive agent Dosing entry antihypertensive medication accept efficacious dose maximum tolerate dose stable least 4 week prior study entry Subjects require clinic sit DBP ≥95 ≤110 mmHg SBP ≥140 ≤180 mmHg average 3 reading current antihypertensive therapy visit 1 2 Exclusion criterion include , limit : Subjects take antihypertensive medication indication ( i.e . arrhythrma , unstable angina , CHF , etc . ) Orthostatic hypotension , define decrease least 20 mmHg systolic 1OmmHg diastolic pressure sit stand blood pressure 2 rmnutes , know fluid depletion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Essential hypertension , doxazosin , ambulatory blood pressure monitoring</keyword>
</DOC>